BioStem Technologies, Inc.
BSEM · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $79 | $215 | $227 | $227 |
| - Cash | $27 | $31 | $27 | $23 |
| + Debt | $3 | $4 | $4 | $5 |
| Enterprise Value | $55 | $187 | $204 | $209 |
| Revenue | $10 | $49 | $73 | $103 |
| % Growth | -78.8% | -32% | -29.5% | – |
| Gross Profit | $9 | $49 | $72 | $99 |
| % Margin | 87.9% | 98.6% | 98.8% | 96.5% |
| EBITDA | $2 | $0 | $5 | $9 |
| % Margin | 14.6% | 0.4% | 7.3% | 8.3% |
| Net Income | $1 | -$1 | $4 | $16 |
| % Margin | 7.3% | -1.1% | 6.2% | 15.1% |
| EPS Diluted | 0.03 | -0.034 | 0.17 | 0.68 |
| % Growth | 188.8% | -119.9% | -75% | – |
| Operating Cash Flow | – | $5 | $4 | $8 |
| Capital Expenditures | – | -$0 | -$0 | -$0 |
| Free Cash Flow | – | $5 | $4 | $8 |